How can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions? (Diabetes Treatment, Multiple Sclerosis, Rheumatoid Arthritis)
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2017
Authors: Wiederkehr S, De Bock E, Chekroun M, Arnould B
Patients with chronic disease are generally required to take long-term treatments to treat their illness and avoid complications. However lack of adherence is very common and represents major barriers to treatment efficiency. The objectives of this study are to evaluate the level of acceptance to medication in chronic diseases patients (Multiple Sclerosis, Diabetes and Rheumatoid Arthritis) in real life; to identify issues and to define priorities for action. Treatment acceptance is not satisfactory in chronic disease patients. General acceptance is mainly driven by patients’ perceived treatment effectiveness, side effects and long term use while socio-demographical and clinical characteristics have a minor contribution. These findings indicate patients’ priorities and unmet needs; however, they must be confirmed using longitudinal data.